O papel dos fenótipos do teste oral de tolerância à glicose na progressão e remissão do diabetes tipo 2
Year: 2025
Type: dissertation
Abstract: BACKGROUND: The heterogeneity of type 2 diabetes is complex and involves dynamic interactions between genetic predisposition, environmental exposures, and distinct metabolic phenotypes. Historically regarded as a chronic and inevitably progressive disease, type 2 diabetes has had its paradigm increasingly challenged by evidence from studies involving patients undergoing bariatric surgery, dietary interventions, and novel pharmacological therapies. These studies have demonstrated that diabetes remission is achievable in a subset of individuals. Since then, scientific interest has grown substantially, accompanied by efforts to identify factors associated with type 2 diabetes remission. Despite the lack of a widely accepted consensus on the definition of remission, disease duration and glycemic control have consistently emerged as key determinants. However, aspects related to the heterogeneity of diabetes pathophysiological pathways have received comparatively limited attention and diabetes is often used as a broad diagnostic label, overlooking the distinct metabolic phenotypes that constitute the disease spectrum. A better understanding of the clinical and metabolic profiles associated both with the onset of distinct T2D phenotypes and with remission is essential to support targeted prevention and personalized care strategies. In this context, the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil), a multicenter cohort with standardized and centralized data collection, offers a unique opportunity to investigate the dynamic metabolic profiles associated with incident T2D phenotypes and remission among individuals with newly diagnosed disease. METHODS: We analyzed data from ELSA-Brasil, which enrolled 15,105 civil servants aged 35–74 from six Brazilian cities between 2008 and 2010, with follow-up assessments conducted in 2012–2014 and 2017–2019. For the incidence analysis, we included participants without diabetes at baseline, confirmed by oral glucose tolerance test (OGTT) and the absence of glucose-lowering medication. Incident T2D was classified into isolated abnormal fasting glucose (FPG ≥126 mg/dL and 2hPG <200 mg/dL) or isolated abnormal 2-hour post-load glucose (2hPG ≥200 mg/dL and FPG <126 mg/dL), excluding those with both abnormalities. For the remission analysis, we included individuals newly diagnosed with T2D at Visit 1 or 2, with follow-up OGTT data available and no history of bariatric surgery. Remission was defined as achieving FPG <126 mg/dL, 2hPG <200 mg/dL, and HbA1c <6.5%, without glucose-lowering medication. Clinical, laboratory, and sociodemographic data were obtained using standardized protocols. Insulin 11 sensitivity was estimated using the Matsuda Index, and hepatic steatosis was assessed by the Fatty Liver Index (FLI). Associations between metabolic factors and diabetes phenotypes or remission were estimated using robust Poisson regression models. RESULTS: Among 845 participants with incident T2D, after excluding those with abnormally elevated glycemia at both moments, 605 were classified with isolated abnormal fasting glucose (34%) or isolated abnormal 2hPG (66%). Higher LDLCholesterol was inversely associated with the isolated abnormal fasting phenotype (RR per 50 mg/dL=0.69; 95%CI: 0.55–0.88), while insulin sensitivity remained positively associated across models (RR=1.17; 95%CI 1.03–1.32). Higher levels of the Fatty Liver Index (FLI) were positively associated with fasting phenotype (RR=1.34; 95%CI: 1.02– 1.77), but lost significance when BMI, hypertension and lifestyle characteristics were added into the model. Heavy alcohol consumption was associated with a higher risk of developing the isolated abnormal fasting glucose phenotype (RR=1.82; 95%CI 1.10– 2.93). In the remission analysis, 752 participants with incident T2D were evaluated, among whom 100 were in diabetes remission at follow-up. Most cases of remission occurred among those initially classified with isolated abnormal 2hPG. In multivariable models, this group showed a higher probability of remission compared to those with isolated fasting glucose impairment (RR=1.95; 95%CI 1.17–3.39), whereas individuals with both abnormalities had a lower probability of remission (RR=0.19; 95%CI 0.04– 0.60). Higher levels of HbA1c and fatty liver index (FLI) were inversely associated with remission across all models (RR=0.39; 95%CI 0.26–0.58 and RR=0.54; 95%CI 0.33– 0.88, respectively). In contrast, anthropometric measures, lipid parameters, and insulin sensitivity (Matsuda index) were not significantly associated with remission in the multivariate models. Stratified analysis by body mass index (BMI) revealed effect modification for certain predictors. Among individuals without obesity (BMI<30 kg/m²), the inverse association between FLI and remission remained significant and slightly stronger (RR=0.44; 95%CI 0.26–0.73), whereas in individuals with obesity the association was attenuated. The positive association between isolated abnormal 2-hour post-load glucose and remission was more pronounced among individuals with obesity (RR: 4.50; 95%CI 1.43–14.15). Higher triglyceride levels were positively associated with remission in the BMI<30 group (RR=1.17; 95%CI 1.03–1.33), while no significant associations were found among individuals with BMI≥30 kg/m². CONCLUSION: The two studies based on the ELSA-Brasil cohort highlight the prognostic relevance of OGTT phenotypes and their association with distinct metabolic profiles in type 2 diabetes. Individuals with isolated abnormal post-load glucose exhibited a lower probability of remission, particularly in the presence of obesity, and were characterized by lower insulin sensitivity and lower hepatic steatosis. Elevated LDLCholesterol was independently associated with this phenotype, pointing to a potential role of lipid metabolism in its development, beyond insulin resistance and hepatic dysfunction. These findings reinforce the need to move beyond a one-size-fits-all model of diabetes, emphasizing phenotypic stratification at diagnosis. Incorporating simple tools such as the OGTT and Fatty Liver Index into routine care may help identify individuals with greater remission potential and guide targeted cost-effective interventions. Recognizing the heterogeneity of type 2 diabetes is essential for advancing both research and clinical practice toward more personalized approaches.
Author: Ferreira, Thaís Soares
Institution: Universidade Federal do Rio Grande do Sul
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7134147613
